{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:54:18Z","timestamp":1780530858442,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Center For Advancing Translational Science of the National Institute of Health","award":["UL1TR000457"],"award-info":[{"award-number":["UL1TR000457"]}]},{"name":"Clinical and Translational Science Center at Weill Cornell Medical College","award":["UL1-TR000457-06"],"award-info":[{"award-number":["UL1-TR000457-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10620-018-5109-1","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T05:52:29Z","timestamp":1526277149000},"page":"2439-2444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5058-5527","authenticated-orcid":false,"given":"Shirley","family":"Cohen-Mekelburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Tafesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Weg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Scherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"5109_CR1","first-page":"143","volume":"52","author":"IG Moraru","year":"2014","unstructured":"Moraru IG, Moraru AG, Andrei M, et al. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania. Rom J Intern Med. 2014;52:143\u2013150.","journal-title":"Rom J Intern Med"},{"key":"5109_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/jgh.12908","volume":"30","author":"JM Lee","year":"2015","unstructured":"Lee JM, Lee KM, Chung YY, et al. Clinical significance of the glucose breath test in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2015;30:990\u2013994.","journal-title":"J Gastroenterol Hepatol"},{"key":"5109_CR3","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1007\/s10620-013-2694-x","volume":"58","author":"SV Rana","year":"2013","unstructured":"Rana SV, Sharma S, Malik A, et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci. 2013;58:2594\u20132598.","journal-title":"Dig Dis Sci"},{"key":"5109_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-230X-9-61","volume":"9","author":"J Klaus","year":"2009","unstructured":"Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz CC. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn\u2019s Disease. BMC Gastroenterol. 2009;9:61.","journal-title":"BMC Gastroenterol"},{"key":"5109_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00004836-200007000-00015","volume":"31","author":"F Castiglione","year":"2000","unstructured":"Castiglione F, Del Vecchio Blanco G, Rispo A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn\u2019s disease. J Clin Gastroenterol. 2000;31:63\u201366.","journal-title":"J Clin Gastroenterol"},{"key":"5109_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1023\/A:1017991313789","volume":"47","author":"D Mishkin","year":"2002","unstructured":"Mishkin D, Boston FM, Blank D, Yalovsky M, Mishkin S. The glucose breath test: a diagnostic test for small bowel stricture(s) in Crohn\u2019s disease. Dig Dis Sci. 2002;47:489\u2013494.","journal-title":"Dig Dis Sci"},{"key":"5109_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2362.1981.tb01841.x","volume":"11","author":"P Rutgeerts","year":"1981","unstructured":"Rutgeerts P, Ghoos Y, Vantrappen G, Eyssen H. Ileal dysfunction and bacterial overgrowth in patients with Crohn\u2019s disease. Eur J Clin Invest. 1981;11:199\u2013206.","journal-title":"Eur J Clin Invest"},{"key":"5109_CR8","doi-asserted-by":"publisher","first-page":"13999","DOI":"10.3748\/wjg.v20.i38.13999","volume":"20","author":"C S\u00e1nchez-Montes","year":"2014","unstructured":"S\u00e1nchez-Montes C, Ortiz V, Bastida G, et al. Small intestinal bacterial overgrowth in inactive Crohn\u2019s disease: influence of thiopurine and biological treatment. World J Gastroenterol. 2014;20:13999\u201314003.","journal-title":"World J Gastroenterol"},{"key":"5109_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gtc.2017.09.008","volume":"47","author":"A Adike","year":"2018","unstructured":"Adike A, DiBaise JK. Small intestinal bacterial overgrowth: nutritional implications, diagnosis, and management. Gastroenterol Clin North Am. 2018;47:193\u2013208.","journal-title":"Gastroenterol Clin North Am"},{"key":"5109_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11894-015-0482-9","volume":"18","author":"A Rezaie","year":"2016","unstructured":"Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.","journal-title":"Curr Gastroenterol Rep"},{"key":"5109_CR11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11894-013-0356-y","volume":"15","author":"M Pimentel","year":"2013","unstructured":"Pimentel M, Mathur R, Chang C. Gas and the microbiome. Curr Gastroenterol Rep. 2013;15:356.","journal-title":"Curr Gastroenterol Rep"},{"key":"5109_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","volume":"51","author":"C Zhong","year":"2017","unstructured":"Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence. J Clin Gastroenterol. 2017;51:300\u2013311.","journal-title":"J Clin Gastroenterol"},{"key":"5109_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775\u2013784.","journal-title":"Am J Gastroenterol"},{"key":"5109_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","volume":"11","author":"WK Lo","year":"2013","unstructured":"Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483\u2013490.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5109_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/ajg.2016.30","volume":"111","author":"M Pimentel","year":"2016","unstructured":"Pimentel M. Breath testing for small intestinal bacterial overgrowth: should we bother? Am J Gastroenterol. 2016;111:307\u2013308.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5109-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5109-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5109-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:40:06Z","timestamp":1557794406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5109-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["5109"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5109-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"8 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"E Scherl has received grant\/research support from Abbott Laboratories (AbbVie), AstraZeneca, Janssen Research & Development, and Pfizer, and serves as a consultant to AbbVie, Janssen Pharmaceutical, and Takeda Pharmaceuticals. The other authors have no relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}